Thomas Wang

A Polygenic Risk Score — a genetic assessment that doctors have hoped could predict coronary heart disease (CHD) in patients — has been found not to be a useful predictive biomarker for disease risk. Read More

A single pill containing low doses of three medications to treat high blood pressure and one to lower cholesterol reduced the estimated risk of cardiovascular disease by 25%, according to a VUMC study. Read More

Thomas Wang, MD, Gottlieb C. Friesinger II Professor of Cardiovascular Medicine and director of the Division of Cardiovascular Medicine, was recently named president-elect of the Association of Professors of Cardiology (APC) for 2018. He will subsequently serve as the president of the group in 2019. Read More

Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read More

The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by Sir William Osler and six other physicians for “the advancement of scientific and practical medicine.” This year, 60 additional physician scientists were elected to the association, including three Vanderbilt faculty members. Read More

Surgeons at Vanderbilt University Medical Center (VUMC) performed five heart transplants in four days to place the institution among an elite group of transplant centers in the country — reaching 1,000 heart transplantations. Read More

Vanderbilt University Medical Center (VUMC) has received a five-year, $2 million award from the National Institutes of Health (NIH) to establish the Vanderbilt Emergency Care Research Training Program. Read More

Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found. Read More

Five current faculty members at Vanderbilt University Medical Center have made this year’s list of scientists whose papers have been cited most frequently by others. Read More

Vanderbilt’s Thomas Wang, M.D., left, Nancy Brown, M.D., and David Bader, Ph.D., explored the human determinants of cardiovascular disease and treatment at last week’s Flexner Discovery Lecture. Read More

Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24. Read More

The keys to longevity have been a source of curiosity and the basis of many research studies for years, yet the mechanisms underlying a person’s ability to live a long life are still not fully understood. Read More

Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency. Read More

When it comes to taking care of our hearts, there is a big divide between what we should do and what we actually do, a new multi-institution study reports. Read More

Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer. Read More

Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world. Read More

While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease. Read More

Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease. Read More

Thomas Wang, M.D., has joined Vanderbilt as director of the Division of Cardiovascular Medicine and the physician-in-chief of the Vanderbilt Heart and Vascular Institute. Read More

Doug Sawyer, M.D., Ph.D., is stepping down as director of the Division of Cardiovascular Medicine. (Photo by Joe Howell) Doug Sawyer, M.D., Ph.D., Lisa M. Jacobson Chair of Cardiovascular Medicine and Professor of Medicine and Pharmacology, will step down as director of the Division of… Read More